February 11, 2016
Recommended Topic Related To:

Inspra

"The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of selexipag (Uptravi, Actelion Registration Ltd) for the treatment of adults with pulmonary arterial hypertension (PAH)./"...

A A A

Inspra




PATIENT INFORMATION

Patients receiving INSPRA should be informed:

  • Not to use strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, nefazodone, ritonavir, and nelfinavir.
  • Not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician.
  • To call their physician if they experience dizziness, diarrhea, vomiting, rapid or irregular heartbeat, lower extremity edema, or difficulty breathing.
  • That periodic monitoring of blood pressure and serum potassium is important [see CONTRAINDICATIONS; WARNINGS AND PRECAUTIONS; and DRUG INTERACTIONS].

Last reviewed on RxList: 6/3/2013
This monograph has been modified to include the generic and brand name in many instances.

Inspra - User Reviews

Inspra User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Inspra sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Hypertension

Get tips on handling your hypertension.